Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Prep Pitch and Connect at the JP Morgan Healthcare Conference
As the healthcare and life sciences industry gears up for the highly anticipated JP Morgan Healthcare Conference later this month, stakeholders
BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
BioUtah, the trade association, common voice, and flag bearer for Utah's life sciences industry, will participate in the 2025 J.P. Morgan 43rd Annual Healthcare Conference. BioUtah to co-host an RSVP-required reception on Sunday night,
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here. OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large,
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical-stage,
ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced that Chairman and Chief Executive Officer, David Hallal,
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, beginning at approximately 9:45 a.
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on ...
Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world​, today announced
GlobalData on MSN
21h
Startline Motor Finance secures $580m credit facility from JP Morgan
The UK-based specialist finance provider said the deal marks the sixth renewal and upsize of its type between the two ...
3d
At JP Morgan conference, health care investors gear up for transformative legal developments
Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...
1d
on MSN
JP Morgan Orders Staff to Return to Office Five Days a Week
JP Morgan goes all out with strict RTO policy, insisting all employees are back at their desks for the full week.
16m
Freshfields and Quinn Emanuel Face Off in Latest JP Morgan-WeRealize Dispute
The banking giant has filed two lawsuits, one in Greece for €916m and one in the U.K., against WeRealize, in an ongoing legal dispute over their co-owned business, Viva Wallet.
1d
JPMorgan files two lawsuits against Greece's Viva Wallet as legal saga continues
Wall Street bank JP Morgan has filed two lawsuits over its investment in fintech Viva Wallet, the latest twist in a legal ...
The Bond Buyer
2d
JP Morgan joins exodus from climate group
The bank, which has been under review by the Texas attorney general over its involvement in the Net-Zero Banking Alliance, ...
Commercial Observer
2d
JP Morgan to Order Staff to Return to Offices Five Days a Week
J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...
2h
Corporate investment stalled by weak demand, not supply, says Sajjid Chinoy of JP Morgan
Over the past decade, corporate investment in India has dropped significantly by 12 percent of GDP and policies should focus ...
BioSpace
1d
Biopharma Heads to JP Morgan Seeking an M&A Spark to Improve Sentiment
M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...
Hosted on MSN
2d
JP Morgan Upgrades P10 (PX)
Fintel reports that on January 7, 2025, JP Morgan upgraded their outlook for P10 (NYSE:PX) from Neutral to Overweight.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
Tesla
New York Stock Exchange
Carvana
Hindenburg
Feedback